OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – August 2021 – AWMF-Registernummer: 021-004
Andreas Sturm, Andreas Stallmach, Raja Atreya, et al.
Zeitschrift für Gastroenterologie (2022) Vol. 60, Iss. 03, pp. 332-418
Closed Access | Times Cited: 63
Andreas Sturm, Andreas Stallmach, Raja Atreya, et al.
Zeitschrift für Gastroenterologie (2022) Vol. 60, Iss. 03, pp. 332-418
Closed Access | Times Cited: 63
Showing 1-25 of 63 citing articles:
Upadacitinib in Crohn’s disease
Axel Dignaß, Philip Esters, Cathrin Flauaus
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 4, pp. 359-370
Closed Access | Times Cited: 7
Axel Dignaß, Philip Esters, Cathrin Flauaus
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 4, pp. 359-370
Closed Access | Times Cited: 7
Treatment strategies in inflammatory bowel diseases
Andreas Stallmach, Raja Atreya, Philip C. Grunert, et al.
Deutsches Ärzteblatt international (2023)
Open Access | Times Cited: 16
Andreas Stallmach, Raja Atreya, Philip C. Grunert, et al.
Deutsches Ärzteblatt international (2023)
Open Access | Times Cited: 16
Anwendung fortgeschrittener Therapien bei chronisch-entzündlichen Darmerkrankungen
Benjamin Misselwitz, Sebastian Zeißig, Stefan Schreiber, et al.
Deleted Journal (2025)
Open Access
Benjamin Misselwitz, Sebastian Zeißig, Stefan Schreiber, et al.
Deleted Journal (2025)
Open Access
Positionspapier der Gesellschaft für Pädiatrische Gastroenterologie und Ernährung (GPGE) zum zulassungsüberschreitenden Gebrauch von für Erwachsene mit CED zugelassenen Biologika und Signalinhibitoren bei Kindern und Jugendlichen
Jan Däbritz, Martin Claßen, K. Krohn, et al.
Zeitschrift für Gastroenterologie (2025)
Open Access
Jan Däbritz, Martin Claßen, K. Krohn, et al.
Zeitschrift für Gastroenterologie (2025)
Open Access
32/m mit Bauchschmerz, Übelkeit, Stuhlunregelmäßigkeiten
Franziska Stallbaum, Thorben W. Fründt, Samuel Huber
Deleted Journal (2025)
Closed Access
Franziska Stallbaum, Thorben W. Fründt, Samuel Huber
Deleted Journal (2025)
Closed Access
Real‐world effectiveness of vedolizumab compared to anti‐TNF agents in biologic‐naïve patients with ulcerative colitis: A two‐year propensity‐score‐adjusted analysis from the prospective, observational VEDOIBD ‐study
Bernd Bokemeyer, Sandra Plachta‐Danielzik, Romina di Giuseppe, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 4, pp. 429-442
Open Access | Times Cited: 12
Bernd Bokemeyer, Sandra Plachta‐Danielzik, Romina di Giuseppe, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 4, pp. 429-442
Open Access | Times Cited: 12
Prioritization in inflammatory bowel disease therapy
Klaus Herrlinger, Eduard F. Stange
Expert Review of Gastroenterology & Hepatology (2023) Vol. 17, Iss. 8, pp. 753-767
Closed Access | Times Cited: 10
Klaus Herrlinger, Eduard F. Stange
Expert Review of Gastroenterology & Hepatology (2023) Vol. 17, Iss. 8, pp. 753-767
Closed Access | Times Cited: 10
To STRIDE or not to STRIDE: a critique of “treat to target” in Crohn´s disease
Klaus Herrlinger, Eduard F. Stange
Expert Review of Gastroenterology & Hepatology (2023) Vol. 17, Iss. 12, pp. 1205-1219
Closed Access | Times Cited: 6
Klaus Herrlinger, Eduard F. Stange
Expert Review of Gastroenterology & Hepatology (2023) Vol. 17, Iss. 12, pp. 1205-1219
Closed Access | Times Cited: 6
Unique Metabolomic and Lipidomic Profile in Serum From Patients With Crohn’s Disease and Ulcerative Colitis Compared With Healthy Control Individuals
Hauke Christian Tews, Franziska Schmelter, Arne Kandulski, et al.
Inflammatory Bowel Diseases (2023) Vol. 30, Iss. 12, pp. 2405-2417
Open Access | Times Cited: 5
Hauke Christian Tews, Franziska Schmelter, Arne Kandulski, et al.
Inflammatory Bowel Diseases (2023) Vol. 30, Iss. 12, pp. 2405-2417
Open Access | Times Cited: 5
Taking IBD Treatment in STRIDE: How Objective Disease Assessment Is Essential for the Successful Implementation of Treat-to-Target Strategies
Andreas Stallmach, Philip C. Grunert
Digestive Diseases and Sciences (2024) Vol. 69, Iss. 3, pp. 657-659
Open Access | Times Cited: 1
Andreas Stallmach, Philip C. Grunert
Digestive Diseases and Sciences (2024) Vol. 69, Iss. 3, pp. 657-659
Open Access | Times Cited: 1
Chronisch-entzündliche Darmerkrankungen
Jost Langhorst, Anna K. Koch
Springer eBooks (2024), pp. 77-89
Closed Access | Times Cited: 1
Jost Langhorst, Anna K. Koch
Springer eBooks (2024), pp. 77-89
Closed Access | Times Cited: 1
Update des Addendums zu den S3-Leitlinien Morbus Crohn und Colitis ulcerosa: Betreuung von Patienten mit chronisch-entzündlichen Darmerkrankungen in Bezug auf COVID-19 (Version 2.0)
Carsten Schmidt, Andreas Stallmach, Andreas Sturm, et al.
Zeitschrift für Gastroenterologie (2024) Vol. 62, Iss. 04, pp. 517-534
Closed Access | Times Cited: 1
Carsten Schmidt, Andreas Stallmach, Andreas Sturm, et al.
Zeitschrift für Gastroenterologie (2024) Vol. 62, Iss. 04, pp. 517-534
Closed Access | Times Cited: 1
Mind-body-medicine and comprehensive lifestyle-modification in patients with Crohn's disease—Feasibility of a randomized controlled trial under pandemic circumstances
Nina Bauer, Claudia Löffler, Özlem Öznur, et al.
Frontiers in Integrative Neuroscience (2022) Vol. 16
Open Access | Times Cited: 6
Nina Bauer, Claudia Löffler, Özlem Öznur, et al.
Frontiers in Integrative Neuroscience (2022) Vol. 16
Open Access | Times Cited: 6
Real-World Effectiveness of Vedolizumab vs Anti-TNF in Biologic-naïve Crohn’s Disease Patients: A 2-year Propensity-score-adjusted Analysis from the VEDOIBD-Study
Bernd Bokemeyer, Sandra Plachta‐Danielzik, Romina di Giuseppe, et al.
Inflammatory Bowel Diseases (2023) Vol. 30, Iss. 5, pp. 746-756
Closed Access | Times Cited: 3
Bernd Bokemeyer, Sandra Plachta‐Danielzik, Romina di Giuseppe, et al.
Inflammatory Bowel Diseases (2023) Vol. 30, Iss. 5, pp. 746-756
Closed Access | Times Cited: 3
Perioperative Low-Dose Prednisolone Treatment Has Beneficial Effects on Postoperative Recovery and Anastomotic Healing in a Murine Colitis Model
Marie-Christin Weber, Jannick Bauer, Annalisa Buck, et al.
Journal of Crohn s and Colitis (2023) Vol. 17, Iss. 6, pp. 950-959
Closed Access | Times Cited: 2
Marie-Christin Weber, Jannick Bauer, Annalisa Buck, et al.
Journal of Crohn s and Colitis (2023) Vol. 17, Iss. 6, pp. 950-959
Closed Access | Times Cited: 2
Stammzelltherapie bei komplexen perianalen Fisteln bei Morbus Crohn: Aktuelle Evidenz und Ausblick
O. Schwandner
Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie (2023) Vol. 148, Iss. 03, pp. 220-227
Closed Access | Times Cited: 2
O. Schwandner
Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie (2023) Vol. 148, Iss. 03, pp. 220-227
Closed Access | Times Cited: 2
Use of Methotrexate in Girls and Women of Childbearing Age, Occurrence of Methotrexate-Exposed Pregnancies and Their Outcomes in Germany: A Claims Data Analysis
Nadine Wentzell, Bianca Kollhorst, Jonas Reinold, et al.
Clinical Drug Investigation (2022) Vol. 43, Iss. 2, pp. 109-117
Open Access | Times Cited: 4
Nadine Wentzell, Bianca Kollhorst, Jonas Reinold, et al.
Clinical Drug Investigation (2022) Vol. 43, Iss. 2, pp. 109-117
Open Access | Times Cited: 4
Crohn-Colitis und Colitis indeterminata
Rahel M. Strobel, Johannes C. Lauscher
Springer Reference Medizin (2024), pp. 1-12
Closed Access
Rahel M. Strobel, Johannes C. Lauscher
Springer Reference Medizin (2024), pp. 1-12
Closed Access
Prospective Evaluation of the Prediction Score for a Mild Course of Crohn’s Disease (PreMiCC) in Newly Diagnosed Patients With Crohn’s Disease: The PROGNOS Study
Wolfgang Kruis, Bernd Bokemeyer, Petra Jessen, et al.
Inflammatory Bowel Diseases (2024)
Open Access
Wolfgang Kruis, Bernd Bokemeyer, Petra Jessen, et al.
Inflammatory Bowel Diseases (2024)
Open Access
The care of children and adolescents with chronic inflammatory bowel disease
Luisa Tischler, Aletta Boerkoel, H Krause, et al.
Deutsches Ärzteblatt international (2024)
Closed Access
Luisa Tischler, Aletta Boerkoel, H Krause, et al.
Deutsches Ärzteblatt international (2024)
Closed Access
The administrative prevalence and pharmacotherapy of chronic inflammatory bowel diseases, 2012–2020
Karsten H. Weylandt, Andrea Wiese, Adelheid Jung, et al.
Deutsches Ärzteblatt international (2024)
Closed Access
Karsten H. Weylandt, Andrea Wiese, Adelheid Jung, et al.
Deutsches Ärzteblatt international (2024)
Closed Access
Integrierte Psychosomatische Versorgung und Rehabilitation
Anke von Sengbusch
Springer eBooks (2024), pp. 309-319
Closed Access
Anke von Sengbusch
Springer eBooks (2024), pp. 309-319
Closed Access
